Marshall Wace’s Celldex Therapeutics CLDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-276,728
| Closed | -$9.41M | – | 2424 |
|
|
2024
Q3 | $9.41M | Sell |
276,728
-1,101,140
| -80% | -$37.4M | 0.01% | 715 |
|
|
2024
Q2 | $51M | Buy |
1,377,868
+479,068
| +53% | +$17.7M | 0.07% | 240 |
|
|
2024
Q1 | $37.7M | Sell |
898,800
-381,284
| -30% | -$16M | 0.06% | 277 |
|
|
2023
Q4 | $50.8M | Buy |
1,280,084
+741,765
| +138% | +$29.4M | 0.09% | 203 |
|
|
2023
Q3 | $14.8M | Buy |
538,319
+248,796
| +86% | +$6.85M | 0.03% | 474 |
|
|
2023
Q2 | $9.82M | Sell |
289,523
-44,143
| -13% | -$1.5M | 0.02% | 639 |
|
|
2023
Q1 | $12M | Sell |
333,666
-333,083
| -50% | -$12M | 0.03% | 553 |
|
|
2022
Q4 | $29.7M | Buy |
666,749
+14,028
| +2% | +$625K | 0.07% | 295 |
|
|
2022
Q3 | $18.3M | Buy |
652,721
+632,698
| +3,160% | +$17.8M | 0.04% | 453 |
|
|
2022
Q2 | $539K | Buy |
+20,023
| New | +$539K | ﹤0.01% | 2119 |
|
|
2021
Q2 | – | Sell |
-20,580
| Closed | -$423K | – | 2159 |
|
|
2021
Q1 | $423K | Buy |
20,580
+8,557
| +71% | +$176K | ﹤0.01% | 1704 |
|
|
2020
Q4 | $211K | Buy |
+12,023
| New | +$211K | ﹤0.01% | 1598 |
|
|
2015
Q4 | – | Sell |
-108,100
| Closed | -$1.14M | – | 987 |
|
|
2015
Q3 | $1.14M | Buy |
+108,100
| New | +$1.14M | 0.01% | 603 |
|